Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males

IA Korostil, H Ali, RJ Guy, B Donovan… - Sexually transmitted …, 2013 - journals.lww.com
Background The National Human Papillomavirus (HPV) Vaccination Program for females
delivering the quadrivalent vaccine Gardasil has been included in the National …

Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination …

EPF Chow, A Carter, T Vickers, CK Fairley… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background In Australia, the government-funded human papillomavirus (HPV)
vaccination programme was introduced in April, 2007, for girls and young women, and in …

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

B Donovan, N Franklin, R Guy, AE Grulich… - The Lancet infectious …, 2011 - thelancet.com
Background Quadrivalent human papillomavirus (HPV) vaccine has high efficacy in clinical
trials but no reports describe its effects at a population level. From July, 2007, Australia was …

Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an …

M Canvin, K Sinka, G Hughes, D Mesher - Sexually transmitted …, 2017 - sti.bmj.com
Background For several decades, diagnoses of genital warts at genitourinary medicine
(GUM) clinics in England had been increasing. In 2008, a national human papillomavirus …

The incidence of genital warts in Australian women prior to the national vaccination program

JML Brotherton, A Heywood, S Heley - Sexual Health, 2009 - CSIRO Publishing
The quadrivalent human papillomavirus (HPV) vaccine currently being delivered to
Australian women aged 12–26 years under the National HPV Vaccination Program …

Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia

DG Regan, DJ Philp, JS Hocking, MG Law - Sexual Health, 2007 - CSIRO Publishing
Background: Vaccines are now available to prevent the development of cervical cancer from
genital human papillomavirus (HPV) infection. The decision to vaccinate depends on a …

Epidemiology of genital warts in the British population: implications for HPV vaccination programmes

P Sonnenberg, C Tanton, D Mesher, E King… - Sexually transmitted …, 2019 - sti.bmj.com
Objectives To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in
the British population, following the introduction of the bivalent (human papillomavirus (HPV) …

Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme

EPF Chow, TRH Read, R Wigan, B Donovan… - Sexually transmitted …, 2015 - sti.bmj.com
Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines
to school girls since mid-2007 and a catch-up programme in the community to women aged …

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

CK Fairley, JS Hocking, LC Gurrin, MY Chen… - Sexually transmitted …, 2009 - sti.bmj.com
Objective: This study aimed to determine if the Australian human papillomavirus (HPV)
vaccination programme has had a population impact on presentations of genital warts …

Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program …

MA Smith, B Liu, P McIntyre, R Menzies… - The Journal of …, 2015 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …